Morningstar1mon
IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M
And Blood Institute of the National Institutes of Health. This Phase II funding follows an NIH SBIR Phase I grant ($247,334) awarded in Fiscal Year 2022 to test the feasibility of the company’s ...
PharmiWeb22d
Enalare Therapeutics Receives Second Component of…
Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...
PharmiWeb22d
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...
manilatimes1mon
IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M
And Blood Institute of the National Institutes of Health. This Phase II funding follows an NIH SBIR Phase I grant ($247,334) awarded in Fiscal Year 2022 to test the feasibility of the company's ...